Check out your Company Bowl for anonymous work chats.
"It is fun to tell people that Exact Sciences is not only looking for scientists but that you can contribute in many ways and have many different kinds of backgrounds and experiences to be able to add value at our company." Our SVP of Human Resources, Sarah Condella, shares more about our hundreds of open positions across a variety of fields. http://ms.spr.ly/6044TU5p6
Exact Sciences has now processed over 500,000 COVID-19 tests. While there is a lot more work to be done to fight this crisis, we are celebrating the impact our team has made and how the people of Exact Sciences continue to rise to the challenge every day.
August is National #WellnessMonth! At Exact Sciences, we are committed to fostering a culture of care and compassion for employees through an individualized and holistic approach. What can you do to improve your well-being this month?
COVID-19 continues to hit our most vulnerable populations. At Exact Sciences, we're committed to investing in every community we serve. We're proud to sponsor XPRIZE, the world's leader in designing and implementing innovative competition models to solve the world's greatest challenges, in their pursuit for quicker, less expensive COVID-19 testing. Read more about their new competition and innovative approach here: https://lnkd.in/eXhG_pW
Let?s take on cancer, together. Exact Sciences is hiring, with new opportunities in IT, Finance, Marketing, and more. Please join us for our next virtual career fair on 8/5, presented in partnership with Urban League of Greater Madison: https://exas.co/2E1jLVw
“We have never been more excited about the future at Exact Sciences” - Kevin Conroy Read more in our recently released 2019 annual report: https://exas.co/3hacOjx
As the COVID-19 pandemic continues to negatively impact our communities, Exact Sciences remains committed to helping those in need.
Oncotype DX is the only test that has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer. Steve Shak, our Chief Medical Officer, discusses the real-world evidence from a prospective clinical survey of the Oncotype DX Breast Recurrence Score® test.
Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. Learn about the risk factors and what you might be able to do to help lower your risk: https://exas.co/31k1Cfg
This #MensHealthMonth and beyond, what will you do to reduce your cancer risk? Learn more about risk factors and prevention here: https://exas.co/2C8Qbwm
